Outlook Therapeutics, Inc. - COM NEW (OTLK)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
450K
Holdings value Q3 2024
$2.4M
Value change Q3 2024
$0
Grand Portfolio weight change Q3 2024
0%
Number of holders
1
Number of buys Q3 2024
0
Number of sells Q3 2024
0
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 450K $2.4M $0 $5.34 1
2024 Q2 450K $3.32M +$1.02M $7.38 1
2024 Q1 316K $3.73M -$7.98M $10.60 3
2023 Q4 29.5M $11.6M +$1.11M $0.39 84
2023 Q3 27.3M $6.06M -$5.45M $0.22 78
2023 Q2 29.2M $50.7M +$3.73M $1.74 84
2023 Q1 27.2M $29.7M -$253K $1.09 79
2022 Q4 27.4M $29.6M +$3.58M $1.08 75
2022 Q3 24M $29.3M -$913K $1.22 72
2022 Q2 24.8M $25.3M -$941K $1.02 69
2022 Q1 25.3M $45.3M +$2.82M $1.78 70
2021 Q4 24M $32.6M +$3.56M $1.36 69
2021 Q3 21.2M $46M +$1.94M $2.17 63
2021 Q2 20.2M $50.4M +$17.3M $2.49 61
2021 Q1 13.5M $30.3M +$16.9M $2.25 48
2020 Q4 5.96M $7.76M +$2.85M $1.30 28
2020 Q3 3.87M $2.79M +$1.52M $0.72 26
2020 Q2 1.68M $2.17M -$2.29M $1.30 17
2020 Q1 5.98M $3.6M +$967K $0.60 17
2019 Q4 514K $310K -$77.4K $0.80 5
2019 Q3 948K $1.41M +$142K $1.49 14
2019 Q2 833K $1.73M +$1.34M $2.07 12
2019 Q1 122K $905K +$896K $7.40 12